As shown in Table 1, there are several differentially expressed genes found to be common across multiple studies and multiple tissue types, such as IFITM1, IFI44, MX1, IRF7, and IRF8, suggesting both local and systemic dysregulation of IFN signaling pathways in SS patients (Table 1). This evidence concerns the gene IFNA1 and synovial sarcoma.